Navigation Links
Consumer group seeks Sibutramine ban

A consumer group has petitioned the Food and Drug Administration to ban the prescription diet drug sibutramine. Public Citizen says the drug, sold as Meridia, is associated with 29 deaths, including 19 from// cardiovascular causes such as heart attacks. But obesity experts say it's difficult to determine if people died because of Meridia or because they were obese, which put them at increased risk for many diseases and premature death.

This is not the first time a diet drug has come under fire. In 1998, the FDA pulled two diet drugs from the market, fenfluramine and dexfenfluramine, because of concern over heart-valve problems. Sibutramine, marketed as Meridia by Abbott Laboratories, works on two brain chemicals that control appetite and make patients feel full. It was approved in 1997 for people who are obese.

Average weight loss from using the medication is 5% to 9% in four to six months. At the time of its approval, experts warned that the drug was not meant for people with heart disease. Studies showed that the drug slightly increased the blood pressure of some patients and substantially increased it in others.
'"/>




Page: 1

Related medicine news :

1. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
2. Identifying What Consumers Look For On Food Stuff Labels
3. Consumers Becoming More Health Conscious Than Calorie Conscious
4. With More Appearance Conscious Consumers The Need For Slimming Products Is Rapidly Rising
5. Consumers of soft drinks to be more alert
6. Consumers Worried About Trans-Fats The Most
7. New Plastic Surgery Unit Set Up In Kolkata To Meet Ever-Increasing Consumer Demand
8. Health care system “Consumer friendly” by 207
9. Chicken Prices Show an Upward Trend – Consumers, Not Scared Chicken Anymor
10. Consumer Court Dismisses Rs 143 Crore Negligence Claim
11. Apex Consumer Court Rejects Rs 143 Cr Medical Negligence Claim
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Consumer group seeks Sibutramine ban

(Date:12/2/2008).... 2 TYRX, Inc., a leader in the de...-device products, today announced the appointment ...esponsible for commercial operations. , , M...e medical device industry. Mr. Elliot joins TYRX f...on providing laser-based antimicrobial and vascula...
(Date:12/2/2008)...-- Services form an integral part of most of,orig... has therefore become,essential for service provi...ket to remain competitive and constantly improve t... (Logo: http://www.newscom.com/cgi-bin/prnh...t & Sullivan ( http://www.medicalimaging.frost...
(Date:12/2/2008)...na Health and Solutions Medical Billing Team Up To...s in a Cloud" as a SaaS Application. , ...mber 2, 2008 -- Making medical insurance claims is...st phase of a "Claims in a Cloud" softwa...delling partners Xena Health and Solutions Medical...
(Date:12/2/2008)...es your over-the-phone interpretation vendor conti...ompleted the call? , Wash...rld of over-the-phone interpretation (OPI), every ...r one minute can add up over the course of a billi...anization employs an over-the-phone interpretation...
Breaking Medicine News(10 mins):Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 2Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 3Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 3Health News:Corporate Modelling Partners Start Selling BPM in Cloud Service 2Health News:Be Aware: Over-the-Phone Interpretation Billing Methods Vary Widely 2Health News:Be Aware: Over-the-Phone Interpretation Billing Methods Vary Widely 3
...nder the age of 65 who lacked health insurance for...2 percent in 2005//. The proportion of uninsured r... County to a high of 27.5 percent in Tyrrell Count...icularly acute problem in Eastern North Carolina; ...
...e occurrence of multiple sclerosis (MS) among wome...mained// stable. Data from a voluntary MS registr... men in the U.S. had multiple sclerosis, by 2000, ...ong women, University of Alabama professor of bios...
...model of infantile spasms, improving the likelihoo...oung children// who suffer from these catastrophic...ile spasms are a specific type of epilepsy seizure...The disorder involves a sudden bending forward and...
...ty School of Medicine has helped confirm the relia...ch// individual's genetic makeup. The Stanford gr...e that the genetic test can identify patients who ...is from chronic hepatitis C infection. That means ...
Other Medicine News:Health News:Number of Uninsured in North Carolina on the Rise 2Health News:Women More Vulnerable to Multiple Sclerosis, Research Shows 2Health News:New Test Helps Identify Hepatitis C Patients at High Risk of Developing Cirrhosis 2Health News:New Test Helps Identify Hepatitis C Patients at High Risk of Developing Cirrhosis 3
(Date:12/1/2008)...Prox1 gene is a two-way switch that, if turned off...ammed so that they lose their identity and become ...IS, Tenn., Dec. 1 Scie...ve discovered that a certain differentiated cell t...uires the constant expression of a gene called Pr...
(Date:12/1/2008)...ecember 1 Following a,R... to procure an MVA-based,third generation smallp...Canada, on behalf of the Canadian Department of Na...n Nordic for the delivery of IMVAMUNE(R). , ...) as part of the,country,s bio-preparedness progr...
(Date:12/1/2008)...wire-FirstCall/ -- Vical Incorporated (Nasdaq: V...n milestone payment from Merck & Co., Inc. bas...ical trial of an investigational plasmid DNA (pDNA...n Vical,s DNA gene delivery technology and encodes...TERT is the subject of separate license agreement....
(Date:11/28/2008)...vember 28 German biotech company,...alized HIV monitoring and,AIDS patient follow-up ... In,the year 2008, 2.5 million patient tests have...hly affordable "CyFlow" system, supporting already... Due to introduction of the,Partec innovation, th...
Breaking Medicine Technology:Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis 2570 1Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis 2570 2Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis 2570 3Death Rates for HIV Patients Decrease Dramatically 23075 1Death Rates for HIV Patients Decrease Dramatically 23075 2Death Rates for HIV Patients Decrease Dramatically 23075 3Best treatment for MS may depend on disease subtype 23072 1Best treatment for MS may depend on disease subtype 23072 2Best treatment for MS may depend on disease subtype 23072 3The Parkinsons Disease Foundation awards 24950 000 in seed grants 3849 1The Parkinsons Disease Foundation awards 24950 000 in seed grants 3849 2The Parkinsons Disease Foundation awards 24950 000 in seed grants 3849 3
...S WIRE)--Mar 22, 2007 - Nutra Pharma,Corp. (OTCBB:...,drugs for HIV and Multiple Sclerosis has today an...harm, has received notification of,acceptance of i...n,Immunology special conference issue., The articl...y,for Multiple Sclerosis; a review of the literatu...
...aplatin Demonstrated Statistically,Significant Imp...BERLIN, March 22, 2007 /PRNewswire-FirstCall/ -- P...nced additional data from,the double-blind, random... SPARC trial (Satraplatin and Prednisone Against,R...e 22nd Annual,European Association of Urology Cong...
Other Medicine Technology:Nutra Pharma Announces Publication of Research on Treatment for,Multiple Sclerosis 2Nutra Pharma Announces Publication of Research on Treatment for,Multiple Sclerosis 3Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 2Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 3Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 4Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 5Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 6Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 7
Measles IgG ELISA test system is designed for the qualitative detection of IgG antibodies to Measles (Rubeola) virus in human serum, and is for in vitro diagnostic use.
Inquire
... Enzymelinked Immunosorbent Assays(ELISA) is inten...on of IgG antibody to Measles Rubeola) virus in hu...or the determination of immune status. Paired sera...rate seroconversion or a significant rise in antib...
The DSL-05-01-MEM Measles IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Measles virus in human serum. This assay is intended fo
Medicine Products: